[ACN Newswire] – By Jason Napodano, CFAFundamentals at Trius Therapeutics (NASDAQ:TSRX) remain solid. I see the development of tedizolid, current in its second phase 3 trial, as low risk. Data from the first phase 3 trial … moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingOn the heels of ponatinib’s Priority Review announcement , Ariad Pharmaceuticals (NASDAQ:ARIA) reported 3Q financial results Wednesday, and on its related conference call emphasized the preparation … moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jason Napodano, CFAOn November 1, 2012, Pfizer (NYSE:PFE) held a conference call ( webcast link ) to discuss its third quarter earnings and financial outlook with investors. In the past, Pfizer’s conference … moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzShares of Endo Pharmaceuticals (NASDAQ:ENDP) are trading at a deep discount to other pharmaceutical companies, with the last dip in price coming on the heels of guidance at the company’s … moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzShares of Pain Therapeutics (NASDAQ:PTIE) are off 25% as partner Pfizer (NYSE:PFE) noted Thursday on its earnings call that Remoxy, PTIE’s lead product, is a challenging asset … moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NEW YORK and CARMIEL, Israel, Nov. 1, 2012 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX, TASE:PLX) today announced that the European Commission (EC) has issued … moreView todays social media effects on PFEView the latest stocks trending across Twitter. Click to view dashboard […]
